A robust braille recognition system

Braille is the most effective means of written communication between visually-impaired and sighted people. This paper describes a new system that recognizes Braille characters in scanned Braille document pages. Unlike most other approaches, an inexpensive flatbed scanner is used and the system requires minimal interaction with the user. A unique feature of this system is the use of context at different levels (from the pre-processing of the image through to the post-processing of the recognition results) to enhance robustness and, consequently, recognition results. Braille dots composing characters are identified on both single and double-sided documents of average quality with over 99% accuracy, while Braille characters are also correctly recognised in over 99% of documents of average quality (in both single and double-sided documents)

Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness.

The molecular mechanisms responsible for the elevated metastatic potential of malignant melanoma are still not fully understood. In order to shed light on the molecules involved in the acquisition by melanoma of a highly aggressive phenotype, we compared the gene expression profiles of two cell clones derived from the human cutaneous metastatic melanoma cell line M14: a highly invasive clone (M14C2/MK18) and a clone (M14C2/C4) with low ability to invade the extracellular matrix (ECM). The highly invasive phenotype of M14C2/MK18 cells was correlated with overexpression of neuropilin-1, activation of a vascular endothelial growth factor (VEGF)-A/VEGFR-2 autocrine loop and secretion of matrix metalloprotease-2. Moreover, in an in vivo murine model, M14C2/MK18 cells displayed a higher growth rate as compared with M14C2/C4 cells, even though in vitro both clones possessed comparable proliferative potential. Microarray analysis in M14C2/MK18 cells showed a strong upregulation of platelet-derived growth factor (PDGF)-C, a cytokine that contributes to angiogenesis, and downregulation of calpain-3, a calcium-dependent thiol-protease that regulates specific signalling cascade components. Inhibition of PDGF-C with a specific antibody resulted in a significant decrease in ECM invasion by M14C2/MK18 cells, confirming the involvement of PDGF-C in melanoma cell invasiveness. Moreover, the PDGF-C transcript was found to be upregulated in a high percentage of human melanoma cell lines (17/20), whereas only low PDGF-C levels were detected in a few melanocytic cultures (2/6). By contrast, inhibition of calpain-3 activity in M14C2/C4 control cells, using a specific chemical inhibitor, markedly increased ECM invasion, strongly suggesting that downregulation of calpain-3 plays a role in the acquisition of a highly invasive phenotype. The results indicate that PDGF-C upregulation and calpain-3 downregulation are involved in the aggressiveness of malignant melanoma and suggest that modulators of these proteins or their downstream effectors may synergise with VEGF‑A therapies in combating tumour-associated angiogenesis and melanoma spread

Multi-photon events with large missing energy in e+e−e+e− collisions at s=192–209 GeV

n/

Long-term results of chemoradiation plus pulsed-dose-rate brachytherapy boost in anal canal carcinoma: A mono-institutional retrospective analysis

Purpose: Concurrent chemoradiation (CCRT) is the standard curative treatment of anal canal cancer (ACC). The role of a brachytherapy (BRT) boost in this setting is still debated. Therefore, the aim of this analysis was to retrospectively evaluate the clinical outcomes in a large cohort of ACC patients treated with CCRT plus BRT boost or external beam radiotherapy (EBRT) boost.Material and methods: Patients with non-metastatic ACC, treated in our department between January 2003 and December 2014 were included in this analysis. The initial treatment was based on EBRT to the pelvis (prescribed dose, 45 Gy/1.8 Gy) plus concurrent chemotherapy (5-fluorouracil and mitomycin-C). Patients received a pulsed-dose-rate BRT boost on the primary tumor (median dose, 20 Gy; range, 13-25 Gy) 2-3 weeks after the end of CCRT. In patients with contraindications to BRT, an EBRT boost (prescribed dose, 16 Gy, 2 Gy/fraction) was delivered immediately after CCRT.Results: One-hundred-twenty-three patients were included in this analysis (median age, 61 years; range, 36-93 years; squamous-cell carcinoma, 78%; HIV+, 6%; median follow-up, 71 months; range, 2-158 months). The actuarial 5-year local control (LC), distant metastasis-free survival, colostomy-free survival, and overall survival (OS) rates were 81.7%, 92.3%, 62.3%, and 74.0%, respectively. At univariate analysis, patients aged <= 65 years (p < 0.010), cT1-2 stage (p = 0.004), and receiving a BRT boost (p = 0.015) showed significantly improved OS. At multivariate analysis, advanced tumor stage cT3-cT4 (HR, 2.12; 95% CI: 1.09-4.14; p = 0.027), and age > 65 years (HR, 3.03; 95% CI: 1.54-5.95; p = 0.001) significantly predicted increased risk of mortality. The crude rate of toxicity-related colostomies was 4.9%.Conclusions: The role of BRT boost in ACC remains unclear since the outcomes were not clearly different compared to CCRT alone. However, further improvement of clinical results in ACC treatment is needed, and therefore prospective trials based on advanced (image-guided/adapted) BRT techniques are warranted

Two-Fermion Production in Electron-Positron Collisions

This report summarizes the results of the two-fermion working group of the LEP2-MC workshop, held at CERN from 1999 to 2000. Recent developments in the theoretical calculations of the two fermion production process in the electron-positron collision at LEP2 center of the mass energies are reported. The Bhabha process and the production of muon, tau, neutrino and quark pairs is covered. On the basis of comparison of various calculations, theoretical uncertainties are estimated and compared with those needed for the final LEP2 data analysis. The subjects for the further studies are identified.Comment: 2-fermion working group report of the LEP2 Monte Carlo Workshop 1999/2000, 113 pages, 24 figures, 35 table

Search for new physics in rare B decays

A search for the decay B^±→K^±K^±π^∓ was performed using data collected by the OPAL detector at LEP. These decays are strongly suppressed in the Standard Model but could occur with a higher branching ratio in supersymmetric models, especially in those with R-parity violating couplings. No evidence for a signal was observed and a 90% confidence level upper limit of 1.29×10^(−4) was set for the branching ratio

Improved measurement of the lifetime of the τ lepton

A new measurement of the τ lifetime is presented. It uses data collected with the Opal detector during 1994, which almost doubles the size of the Opal τ sample. Two statistically independent techniques are used: an impact parameter analysis of one-prong decay tracks and a fit to the decay length distribution of three-prong decays. The lifetime obtained from the 1994 data by combining the results of these methods is τ(τ) = 289.7 ± 2.5 (stat)± 1.5 (sys) fs. When combined with the previous Opal τ lifetime measurement the improved τ lifetime is τ(τ) = 289.2 ± 1.7 (stat.) ± 1.2 (sys.) fs